CClinicalTrials.gg
CompletedNCT06407908Updated Aug 14, 2024

Urdu Translation Of Pediatric Version Of Eating Assessment Tool

An observational study in Cerebral Palsy, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 3 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-14.

Sponsored by Riphah International University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
42
Ages
3 Years to 15 Years
Sex
All
01

Study summary

Dysphagia encompasses challenges encountered during the many stages of swallowing, including the oral phase, commencement of the swallow, pharyngeal phase, and esophageal phase. The incidence of pediatric dysphagia is on the rise as a result of advancements in medical care that have led to higher survival rates among infants born prematurely, with low birth weight, and with complex medical disorders. The Eating Assessment Tool (EAT-10), consisting of 10 items, was first developed for infant patients.

(PEDI-EAT-10) will be translated into Urdu language by using forward backwards translation method. Two bilingual speakers expert in both Urdu and English languages will assist the researcher in the forward translation of the tool. This final translated version will be then tested for validity and reliability on all participants of the study. The psychometric properties of the tool will be assessed including reliability, internal consistency, and item discrimination.

Read the detailed description

A mix method approach will be applied

  1. Forward translation
  2. Reconciliation of items
  3. Backward translation
  4. Review of forward and backward translation
  5. Pre-testing (cognitive interviewing)
  6. Validation study The process of translation followed the guidelines in the translation manual. Translators translate the pediatric version of eating assessment tool (Pedi-EAT-10), independently from each other into the Urdu language considering the following guidelines: using natural language acceptable to the broader public, performing a clear, simple, and understandable translation, avoiding lengthy and complicated sentences. This will be followed by a backward translation to ensure that the content, from the conceptual point of view, had not been modified in the translation. A native English translator was requested to carry out the back-translation, and all discrepancies were identified and corrected. To show whether all items are easily understood and acceptable to the patients, pretesting the final translated questionnaire will be conducted by administering it to patients with a varying education level. The questions that were not easily understood were discussed and redrafted by a panel of researchers until all interviewees understood all items.
02

Conditions studied

  • Cerebral Palsy

Browse trials for

Keywords

  • validation
  • translation
  • eating disorder
  • PEDI-EAT-10
03

In context

Cerebral Palsy

1,853 studies on the registry are indexed under Cerebral Palsy; 437 are open to participants now.

This study's enrollment of 42 is below the median of 63 across 454 observational studies indexed under Cerebral Palsy.

Browse Cerebral Palsy studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The sample size is 42.

Inclusion criteria

  • Parents of children diagnosed with eating disorders
  • Age from 3 to 15 years

Exclusion criteria

Exclusion Criteria:

  • Parents with children Unable to understand the questionnaire
  • Parents with children who have Intellectual disability and any organic type of incontinence, neurological or anatomical problems
  • Parents with who have children Severe cognitive decline or dementia
  • Parents with children cannot understand Urdu.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
42 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Pediatric Version of the Eating Assessment Tool (Pedi-EAT-10)

    This resource is essential for determining how these obstacles affect a child's health and food consumption. The pediatric version is specially designed to evaluate a child's eating and swallowing skills, taking into consideration their specific developmental and physiological needs.

    Time frame: 6 months

07

Study locations

1 site
  • Riphah International University
    Lahore, Punjab 54000, Pakistan
08

References and documents

Publications

  • Varni JW, Limbers CA, Neighbors K, Schulz K, Lieu JE, Heffer RW, Tuzinkiewicz K, Mangione-Smith R, Zimmerman JJ, Alonso EM. The PedsQL Infant Scales: feasibility, internal consistency reliability, and validity in healthy and ill infants. Qual Life Res. 2011 Feb;20(1):45-55. doi: 10.1007/s11136-010-9730-5. Epub 2010 Aug 22. PubMed 20730626 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06407908
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
May 9, 2024
Start date
May 15, 2024
Primary completion
Jun 28, 2024
Completion
Jun 28, 2024
Last update
Aug 14, 2024

Study contacts

Fatima Ahsan, MS*
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion